Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Arzneimittelforschung : Durch innovationen zum markterfolg / / Hans-Harald Sedlacek
| Arzneimittelforschung : Durch innovationen zum markterfolg / / Hans-Harald Sedlacek |
| Autore | Sedlacek H. H. |
| Pubbl/distr/stampa | Berlin, [Germany] ; ; Boston, [Massachusetts] : , : De Gruyter, , 2015 |
| Descrizione fisica | 1 online resource (308 p.) |
| Disciplina | 338.476151 |
| Soggetto topico |
Pharmaceutical industry
Drug development Drugs |
| Soggetto genere / forma | Electronic books. |
| ISBN |
3-11-040352-8
3-11-040362-5 |
| Classificazione | VS 5351 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Nota di contenuto | Frontmatter -- Vorwort -- Haftungsausschluss -- Inhalt -- 1. Probleme der Pharmaforschung und das Anliegen dieses Buches -- 2. Grundlagen -- 3. Zur Frage nach den Fähigkeiten und Eigenschaften -- 4. Von der Verantwortung der Unternehmensleitung -- 5. Die Bedeutung der Rahmenbedingungen -- 6. Der Analyse-, Bewertungs- und Entscheidungsprozess -- 7. Die Produktentwicklung -- 8. Beispiele, um innovationsschädliches Verhalten zu verdeutlichen -- 9. Zusammenfassung -- Sachregister -- Über den Autor |
| Record Nr. | UNINA-9910461419903321 |
Sedlacek H. H.
|
||
| Berlin, [Germany] ; ; Boston, [Massachusetts] : , : De Gruyter, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Immunologie - die Immunabwehr des Menschen : Entstehung, abwehr und behandlungsmöglichkeiten / / Hans-Harald Sedlacek ; Lektorat, Anja Möbius
| Immunologie - die Immunabwehr des Menschen : Entstehung, abwehr und behandlungsmöglichkeiten / / Hans-Harald Sedlacek ; Lektorat, Anja Möbius |
| Autore | Sedlacek H. H. |
| Edizione | [2. Auflage.] |
| Pubbl/distr/stampa | Berlin, Germany ; ; Boston, Massachusetts : , : De Gruyter, , 2014 |
| Descrizione fisica | 1 online resource (806 p.) |
| Disciplina | 616.079 |
| Soggetto topico |
Immunology
Immune system |
| Soggetto genere / forma | Electronic books. |
| ISBN |
3-11-040792-2
3-11-033534-4 |
| Classificazione | WF 9800 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Nota di contenuto | Frontmatter -- Zum Inhalt -- Haftungsausschluss -- Inhalt -- 1. Die unterschiedlichen Abwehrsysteme -- 2. Die mechanischen und funktionellen Körperschranken -- 3. Die angeborene Immunabwehr -- 4. Die erworbene Immunabwehr -- 5. Der Einfluss des Nervensystems auf das Immunsystem -- 6. Herausforderungen und Fehlentwicklungen der Immunabwehr -- 7. Arzneimittel und Zubereitungen zur Beeinflussung der Immunabwehr -- 8. Anlagen -- Sachregister |
| Record Nr. | UNINA-9910463265103321 |
|
Sedlacek H. H.
|
||
| Berlin, Germany ; ; Boston, Massachusetts : , : De Gruyter, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Kreativität in der medizinischen Forschung : Fakten und Forderungen / / Hans-Harald Sedlacek, Petra Netter
| Kreativität in der medizinischen Forschung : Fakten und Forderungen / / Hans-Harald Sedlacek, Petra Netter |
| Autore | Sedlacek H. H. |
| Pubbl/distr/stampa | Berlin, [Germany] ; ; Boston, [Massachusetts] : , : De Gruyter, , 2018 |
| Descrizione fisica | 1 online resource (324 pages) : illustrations |
| Disciplina | 610.72/4 |
| Soggetto topico |
Clinical medicine - Research
Medicine, Experimental |
| Soggetto genere / forma | Electronic books. |
| ISBN | 3-11-047720-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | ger |
| Nota di contenuto | Frontmatter -- Vorwort -- Inhalt -- 1. Der Innovationsbedarf in der Medizin -- 2. Kreativität und kreative Personen -- 3. Die Innovation -- 4. Ein Rückblick: Kreative Personen als Urheber bedeutender medizinischer Innovationen -- 5. Die wesentlichen Folgerungen aus den aufgeführten kreativen und innovativen Leistungen -- 6. Die kreative Gruppe als Ort der Zusammenarbeit, Kritik und Entscheidung -- 7. Die kreative Organisation zur Schaffung von medizinischen Innovationen -- 8. Die kreative Gesellschaft als Mutterboden für medizinische Innovationen -- 9. Zusammenfassung -- 10. Haftungsausschluss -- Sachregister -- Über die Autoren |
| Record Nr. | UNINA-9910467616603321 |
|
Sedlacek H. H.
|
||
| Berlin, [Germany] ; ; Boston, [Massachusetts] : , : De Gruyter, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid
| Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid |
| Autore | Sedlacek H. H. |
| Pubbl/distr/stampa | Weinheim, Germany : , : VCH, , 1996 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
615.1072
615.19 |
| Soggetto topico | Drugs - Research - Methodology |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-84267-2
9786611842673 3-527-61501-6 3-527-61500-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Ways to Successful Strategies in Drug Research and Development; Contents; I Introduction; A Characterization of the pharmaceutical market; B Driving forces for the future; C Controls on pricing; D Control on utilization; E Perspectives; II The ethical background; A Definition of ethics; 1 Moral responsibility; 2 Moral values and rules; B Changes in moral values; 1 Social changes in understanding; 2 Social discourse, public opinion and pressures; 3 The role of science; C Ethical goals; 1 Health care; 2 Research for new drugs; Selection of the R&D project; Human rights; 3 Setting of priorities
4 Responsibility of social partnersIII The research and development project; A The process of research and development; B The innovation process; C The evaluation of a project; 1 Pharmacological profile; 2 Medical needs; 3 Market and turnover potential; 4 Risk factors; 5 Activities and expenses up till launch and post-launch; 6 Estimated success of marketing; 7 Variability and accuracy of project evaluation; D The comparison of the company's own projects; 1 Innovation and expertise; 2 Turnover potential, costs and overall risks; 3 Development time and market position E The selection of main R&D areas, goals and strategies1 SWOT analysis; 2 Selection of main R&D area; 3 Definition of goals; 4 Formulation of strategies; IV Measures to reduce risks; A Choice of technology; B Reinforced selection of research projects; C Designation of multiple goals and partnerships; V Project management; A Historical context; B Organizational theories; 1 Organization structure; 2 Life cycle models and growth; 3 Technology transfer and communication; 4 Creative group problem solving; VI Corporate and technology strategy; A Technology strategy; B Technology strategy vectors 1 Magnitude2 Direction; C Technology strategy archetypes; VII Leadership and management; A Leadership theories; B What is leadership and management in R&D?; C Leadership and structure; D The matrix challenges; 1 Coexistence of vertical and lateral structures; 2 Performance evaluation; The project manager; Individual team members; The team; Functional and discipline heads; The head of project management; E Characteristics of the good leader; VIll Managing for innovation; A Motivation; 1 Motivation theories; 2 Basic conditions for motivation in R&D; 3 Matching motivational needs to the job Three work-related needsExpression of motivational needs; 4 The motivated and creative R&D organization; B Culture; 1 The outer level: manifestations; 2 Below the surface: justdication; 3 At the heart of culture: core ideology; 4 Culture and creativity; C Organizational system; 1 Recruitment; 2 Performance appraisal and reward systems; 3 Decision-making and approval systems; 4 Information systems; D Organizational structures and activities; IX The social and political bearings on innovation; A Background; B Constraining pressures; C Economic constraints; D The role of the industry X Ethical obligations |
| Record Nr. | UNINA-9910144101403321 |
|
Sedlacek H. H.
|
||
| Weinheim, Germany : , : VCH, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid
| Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid |
| Autore | Sedlacek H. H. |
| Pubbl/distr/stampa | Weinheim, Germany : , : VCH, , 1996 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
615.1072
615.19 |
| Soggetto topico | Drugs - Research - Methodology |
| ISBN |
1-281-84267-2
9786611842673 3-527-61501-6 3-527-61500-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Ways to Successful Strategies in Drug Research and Development; Contents; I Introduction; A Characterization of the pharmaceutical market; B Driving forces for the future; C Controls on pricing; D Control on utilization; E Perspectives; II The ethical background; A Definition of ethics; 1 Moral responsibility; 2 Moral values and rules; B Changes in moral values; 1 Social changes in understanding; 2 Social discourse, public opinion and pressures; 3 The role of science; C Ethical goals; 1 Health care; 2 Research for new drugs; Selection of the R&D project; Human rights; 3 Setting of priorities
4 Responsibility of social partnersIII The research and development project; A The process of research and development; B The innovation process; C The evaluation of a project; 1 Pharmacological profile; 2 Medical needs; 3 Market and turnover potential; 4 Risk factors; 5 Activities and expenses up till launch and post-launch; 6 Estimated success of marketing; 7 Variability and accuracy of project evaluation; D The comparison of the company's own projects; 1 Innovation and expertise; 2 Turnover potential, costs and overall risks; 3 Development time and market position E The selection of main R&D areas, goals and strategies1 SWOT analysis; 2 Selection of main R&D area; 3 Definition of goals; 4 Formulation of strategies; IV Measures to reduce risks; A Choice of technology; B Reinforced selection of research projects; C Designation of multiple goals and partnerships; V Project management; A Historical context; B Organizational theories; 1 Organization structure; 2 Life cycle models and growth; 3 Technology transfer and communication; 4 Creative group problem solving; VI Corporate and technology strategy; A Technology strategy; B Technology strategy vectors 1 Magnitude2 Direction; C Technology strategy archetypes; VII Leadership and management; A Leadership theories; B What is leadership and management in R&D?; C Leadership and structure; D The matrix challenges; 1 Coexistence of vertical and lateral structures; 2 Performance evaluation; The project manager; Individual team members; The team; Functional and discipline heads; The head of project management; E Characteristics of the good leader; VIll Managing for innovation; A Motivation; 1 Motivation theories; 2 Basic conditions for motivation in R&D; 3 Matching motivational needs to the job Three work-related needsExpression of motivational needs; 4 The motivated and creative R&D organization; B Culture; 1 The outer level: manifestations; 2 Below the surface: justdication; 3 At the heart of culture: core ideology; 4 Culture and creativity; C Organizational system; 1 Recruitment; 2 Performance appraisal and reward systems; 3 Decision-making and approval systems; 4 Information systems; D Organizational structures and activities; IX The social and political bearings on innovation; A Background; B Constraining pressures; C Economic constraints; D The role of the industry X Ethical obligations |
| Record Nr. | UNISA-996217051103316 |
|
Sedlacek H. H.
|
||
| Weinheim, Germany : , : VCH, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid
| Ways to successful strategies in drug research and development / / H. Harald Sedlacek, Alice M. Sapienza, Volker Eid |
| Autore | Sedlacek H. H. |
| Pubbl/distr/stampa | Weinheim, Germany : , : VCH, , 1996 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
615.1072
615.19 |
| Soggetto topico | Drugs - Research - Methodology |
| ISBN |
1-281-84267-2
9786611842673 3-527-61501-6 3-527-61500-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Ways to Successful Strategies in Drug Research and Development; Contents; I Introduction; A Characterization of the pharmaceutical market; B Driving forces for the future; C Controls on pricing; D Control on utilization; E Perspectives; II The ethical background; A Definition of ethics; 1 Moral responsibility; 2 Moral values and rules; B Changes in moral values; 1 Social changes in understanding; 2 Social discourse, public opinion and pressures; 3 The role of science; C Ethical goals; 1 Health care; 2 Research for new drugs; Selection of the R&D project; Human rights; 3 Setting of priorities
4 Responsibility of social partnersIII The research and development project; A The process of research and development; B The innovation process; C The evaluation of a project; 1 Pharmacological profile; 2 Medical needs; 3 Market and turnover potential; 4 Risk factors; 5 Activities and expenses up till launch and post-launch; 6 Estimated success of marketing; 7 Variability and accuracy of project evaluation; D The comparison of the company's own projects; 1 Innovation and expertise; 2 Turnover potential, costs and overall risks; 3 Development time and market position E The selection of main R&D areas, goals and strategies1 SWOT analysis; 2 Selection of main R&D area; 3 Definition of goals; 4 Formulation of strategies; IV Measures to reduce risks; A Choice of technology; B Reinforced selection of research projects; C Designation of multiple goals and partnerships; V Project management; A Historical context; B Organizational theories; 1 Organization structure; 2 Life cycle models and growth; 3 Technology transfer and communication; 4 Creative group problem solving; VI Corporate and technology strategy; A Technology strategy; B Technology strategy vectors 1 Magnitude2 Direction; C Technology strategy archetypes; VII Leadership and management; A Leadership theories; B What is leadership and management in R&D?; C Leadership and structure; D The matrix challenges; 1 Coexistence of vertical and lateral structures; 2 Performance evaluation; The project manager; Individual team members; The team; Functional and discipline heads; The head of project management; E Characteristics of the good leader; VIll Managing for innovation; A Motivation; 1 Motivation theories; 2 Basic conditions for motivation in R&D; 3 Matching motivational needs to the job Three work-related needsExpression of motivational needs; 4 The motivated and creative R&D organization; B Culture; 1 The outer level: manifestations; 2 Below the surface: justdication; 3 At the heart of culture: core ideology; 4 Culture and creativity; C Organizational system; 1 Recruitment; 2 Performance appraisal and reward systems; 3 Decision-making and approval systems; 4 Information systems; D Organizational structures and activities; IX The social and political bearings on innovation; A Background; B Constraining pressures; C Economic constraints; D The role of the industry X Ethical obligations |
| Record Nr. | UNINA-9910830760803321 |
|
Sedlacek H. H.
|
||
| Weinheim, Germany : , : VCH, , 1996 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||